secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K/A
Filed at:   2021-09-17T23:59:59+00:00
Accession:  0001628280-21-018843
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia board adopts annual say-on-pay votes following shareholder advisory vote
--------------------------------------------------------------------------------

- Board determined to hold annual say-on-pay votes after 56,605,305 shares (approx. 92% of votes cast) favored a 1-year frequency.
- Only 956,039 shares voted for 2 years and 2,443,425 for 3 years; 1,841,663 abstained; 31,597,699 broker non-votes.
- Decision aligns with board's recommendation in proxy statement for the 2021 Annual Meeting.
- Annual say-on-pay will continue until the next required advisory vote on frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000162828021018843/0001628280-21-018843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000162828021018843/auph-20210607.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-018843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer